Literature DB >> 15464254

Hepatotoxicity due to a formulation of Ganoderma lucidum (lingzhi).

Man-Fung Yuen, Philip Ip, Wai-Kuen Ng, Ching-Lung Lai.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15464254     DOI： 10.1016/j.jhep.2004.06.016

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  4 in total

Review 1.  Immunomodulatory dietary polysaccharides: a systematic review of the literature.

Authors:  Jane E Ramberg; Erika D Nelson; Robert A Sinnott
Journal:  Nutr J       Date:  2010-11-18       Impact factor: 3.271

2.  In silico Identification and Mechanism Exploration of Hepatotoxic Ingredients in Traditional Chinese Medicine.

Authors:  Qihui Wu; Chuipu Cai; Pengfei Guo; Meiling Chen; Xiaoqin Wu; Jingwei Zhou; Yunxia Luo; Yidan Zou; Ai-Lin Liu; Qi Wang; Zaoyuan Kuang; Jiansong Fang
Journal:  Front Pharmacol       Date:  2019-05-03       Impact factor: 5.810

Review 3.  The beneficial effects of Ganoderma lucidum on cardiovascular and metabolic disease risk.

Authors:  Sze Wa Chan; Brian Tomlinson; Paul Chan; Christopher Wai Kei Lam
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

4.  A double-blind, randomised, placebo-controlled trial of Ganoderma lucidum for the treatment of cardiovascular risk factors of metabolic syndrome.

Authors:  Nerida L Klupp; Hosen Kiat; Alan Bensoussan; Genevieve Z Steiner; Dennis H Chang
Journal:  Sci Rep       Date:  2016-08-11       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.